It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Spaceflight is known to induce severe systemic bone loss and muscle atrophy of astronauts due to the circumstances of microgravity. We examined the influence of artificially produced 2G hypergravity on mice for bone and muscle mass with newly developed centrifuge device. We also analyzed the effects of microgravity (mostly 0G) and artificial produced 1G in ISS (international space station) on mouse bone mass. Experiment on the ground, the bone mass of humerus, femur and tibia was measured using micro-computed tomography (μCT), and the all bone mass was significantly increased in 2G compared with 1G control. In tibial bone, the mRNA expression of bone formation related genes such as Osx and Bmp2 was elevated. The volume of triceps surae muscle was also increased in 2G compared with 1G control, and the mRNA expression of myogenic factors such as Myod and Myh1 was elevated by 2G. On the other hand, microgravity in ISS significantly induced the loss of bone mass on humerus and tibia, compared with artificial 1G induced by centrifugation. Here, we firstly report that bone and muscle mass are regulated by the gravity with loaded force in both of positive and negative on the ground and in the space.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Tokyo University of Agriculture and Technology, Department of Biotechnology and Life Science, Koganei, Japan (GRID:grid.136594.c)
2 JEM Utilization Center, Human Spaceflight Technology Directorate, JAXA, Tsukuba, Japan (GRID:grid.136594.c)
3 Tokyo University of Agriculture and Technology, Institute of Global Innovation Research, Koganei, Japan (GRID:grid.136594.c)
4 Tokyo University of Agriculture and Technology, Institute of Global Innovation Research, Koganei, Japan (GRID:grid.136594.c); Rheumatology and Musculoskeletal Sciences, University of Oxford, Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948)
5 JEM Utilization Center, Human Spaceflight Technology Directorate, JAXA, Tsukuba, Japan (GRID:grid.4991.5)
6 Tokyo University of Agriculture and Technology, Department of Biotechnology and Life Science, Koganei, Japan (GRID:grid.136594.c); Tokyo University of Agriculture and Technology, Institute of Global Innovation Research, Koganei, Japan (GRID:grid.136594.c)